The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism. (Q35928870)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

review article

1 reference

title

The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Edward Nemeth

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

David Martin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

26 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Renal Physiology

4 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

F253-64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15507543%20AND%20SRC:MED&resulttype=core&format=json

Proliferation in hyperplastic human and normal rat parathyroid glands: role of phosphate, calcitriol, and gender.

4 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Dynamics of skeletal resistance to parathyroid hormone in the rat: effect of renal failure and dietary phosphorus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The calcemic response to PTH in the rat: effect of elevated PTH levels and uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calcium receptor and regulation of parathyroid hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Rat calcium-sensing receptor is regulated by vitamin D but not by calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Importance of arachidonic acid as a mediator of parathyroid gland response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The pathogenesis of parathyroid gland hyperplasia in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Effect of phosphate on parathyroid hormone secretion in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Regulation of parathyroid vitamin D receptor expression by extracellular calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calcium-sensing by parathyroid glands in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Effects of a calcimimetic compound and naturally activating mutations on the human Ca2+ receptor and on Ca2+ receptor/metabotropic glutamate chimeric receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Analysis of renal bone disease treatment in dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Monoclonal anti-parathyroid antibodies interfering with a Ca2+-sensor of human parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Parathyroid hormone gene expression in hypophosphatemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Pathologic study of parathyroid glands in tertiary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The PTH-calcium curve and the set point of calcium in primary and secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Sigmoidal relationship between parathyroid hormone secretion rate and plasma calcium concentration in calves

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

RNA-Protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calcimimetic and calcilytic drugs: just for parathyroid cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Pharmacological regulation of parathyroid hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Pharmacodynamics of the Type II Calcimimetic Compound Cinacalcet HCl

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calcimimetics with potent and selective activity on the parathyroid calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Long-term intravenous calcitriol in secondary hyperparathyroidism: the role of technetium-99m-MIBI scintigraphy in predicting the response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Cardiac valve calcification in haemodialysis patients: role of calcium-phosphate metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Pathogenesis of refractory secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Calreticulin inhibits vitamin D's action on the PTH gene in vitro and may prevent vitamin D's effect in vivo in hypocalcemic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Evidence that resistance to the calcemic action of parathyroid hormone in rats with acute uremia is caused by phosphate retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Trends in the incidence of renal replacement therapy for end-stage renal disease in Europe, 1990-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

An Estimation of the Parathyroid Hormone Secretion Rate in Vitamin D Deficient Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Bone marrow stem cells contribute to healing of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004

Hyperparathyroidism and 1,25-Dihydroxyvitamin D Deficiency in Mild, Moderate, and Severe Renal Failure*

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00302.2004